A57-year-old man comes to see you for follow-up 4 weeks after being discharged from hospital for unstable angina. His coronary angiogram showed moderate nonstenotic disease in two vessels. The cardiologist asks you to follow up on his fasting lipid profile since it was not checked in the hospital. His T-chol is 240 mg/dL, LDL 120 mg/dL, HDL 50 mg/dL, and triglycerides 130 mg/dL.For the above patient with dyslipidemia, select the most appropriate treatment.

**Core Concept**
The management of dyslipidemia involves identifying the type of lipid disorder and selecting a treatment that addresses the underlying pathophysiology. In this case, the patient has a high LDL (bad) cholesterol level, which is a major risk factor for cardiovascular disease.

**Why the Correct Answer is Right**
The patient's high LDL level is due to an imbalance between the production and clearance of LDL particles. Statins are the first-line treatment for high LDL levels because they inhibit the enzyme HMG-CoA reductase, which is involved in the production of cholesterol in the liver. By reducing cholesterol production, statins lower LDL levels and reduce the risk of cardiovascular events. In this case, the patient's LDL level is significantly elevated, making a statin an appropriate choice.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because bile acid sequestrants, such as cholestyramine, are not typically used as first-line treatment for high LDL levels. They work by binding to bile acids in the gut and promoting their excretion, which indirectly reduces cholesterol production. However, they are often associated with gastrointestinal side effects and are not as effective as statins in lowering LDL levels.
**Option B:** This option is incorrect because fibrates, such as fenofibrate, are typically used to treat high triglyceride levels, not high LDL levels. While they may have some effect on LDL levels, they are not the best choice for this patient.
**Option C:** This option is incorrect because niacin, or nicotinic acid, can be used to treat high LDL levels, but it is not typically the first choice due to its side effect profile, which includes flushing, gastrointestinal symptoms, and hyperglycemia.
**Option D:** This option is incorrect because ezetimibe is a cholesterol absorption inhibitor that can be used in combination with a statin to treat high LDL levels. However, it is not typically used as monotherapy for high LDL levels.

**Clinical Pearl / High-Yield Fact**
When selecting a treatment for dyslipidemia, remember that statins are the first-line treatment for high LDL levels due to their efficacy and safety profile. However, it's essential to consider the patient's individual risk factors and medical history to determine the best treatment approach.

**Correct Answer:** C. Niacin is not the best answer though, the correct answer is actually **D**. Ezetimibe or a combination of a statin and a bile acid sequestrant would be more appropriate.

✓ Correct Answer: D. hepatic hydroxymethylglutaryl coenzyme A (HMG-Co) reductase inhibitors (lovastatin, simvastatin, pravastatin)